Varney; Mark A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Varney; Mark A..The latest application filed is for "cycloalkylamines as monoamine reuptake inhibitors".

Company Profile

1.10.16

Varney; Mark A. - Laguna Nigel CA
Varney; Mark A. - Laguna Niguel CA
Varney; Mark A. - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cycloalkylamines as monoamine reuptake inhibitors Grant 10,562,878 - Shao , et al. Feb	2020-02-18
Cycloalkylamines As Monoamine Reuptake Inhibitors App 20180230120 - SHAO; Liming ; et al.	2018-08-16
Cycloalkylamines as monoamine reuptake inhibitors Grant 9,868,718 - Shao , et al. January 16, 2	2018-01-16
Phenyl Substituted Cycloalkylamines As Monoamine Reputake Inhibitors App 20170204050 - SHAO; Liming ; et al.	2017-07-20
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors Grant 9,586,888 - Shao , et al. March 7, 2	2017-03-07
Cycloalkylamines As Monoamine Reuptake Inhibitors App 20150126511 - SHAO; Liming ; et al.	2015-05-07
Cycloalkylamines as monoamine reuptake inhibitors Grant 8,877,975 - Shao , et al. November 4, 2	2014-11-04
Phenyl Substituted Cycloalkylamines As Monoamine Reuptake Inhibitors App 20140121282 - SHAO; Liming ; et al.	2014-05-01
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors Grant 8,669,291 - Shao , et al. March 11, 2	2014-03-11
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders App 20120123164 - CARON; Judy ; et al.	2012-05-17
Tetralone-based monoamine reuptake inhibitors Grant 8,053,603 - Shao , et al. November 8, 2	2011-11-08
Fluoro-substituted inhibitors of D-amino acid oxidase Grant 7,884,124 - Heffernan , et al. February 8, 2	2011-02-08
Cycloalkylamines As Monoamine Reuptake Inhibitors App 20100190861 - Shao; Liming ; et al.	2010-07-29
Combinations of Eszopiclone and O-Desmethylvenlafaxine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders App 20090111818 - Caron; Judy ; et al.	2009-04-30
Combinations of Eszopiclone and an Antidepressant App 20090111817 - Caron; Judy ; et al.	2009-04-30
Phenyl Substituted Cycloalkylamines As Monoamine Reuptake Inhibitors App 20090005456 - Shao; Liming ; et al.	2009-01-01
Combinations of Eszopiclone and Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-N-Methyl-1-Napthalenamine or Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine, and Methods of Treatment of Menopause and Mood, Anxiety, and Cognitive Disorders App 20080293726 - Caron; Judy ; et al.	2008-11-27
Treatment of anxiety with eszopiclone App 20080175903 - Hopkins; Seth C. ; et al.	2008-07-24
Fused heterocyclic inhibitors of D-amino acid oxidase App 20080058395 - Heffernan; Michele L. R. ; et al.	2008-03-06
Fluoro-substituted Inhibitors Of D-amino Acid Oxidase App 20080004327 - Heffernan; Michele L. R. ; et al.	2008-01-03
Cycloalkylamines as monoamine reuptake inhibitors App 20070203111 - Shao; Liming ; et al.	2007-08-30
Tetralone-based monoamine reuptake inhibitors App 20070197588 - Shao; Liming ; et al.	2007-08-23
Methods of modulating processes mediated by excitatory amino acid receptors Grant 6,956,049 - Cosford , et al. October 18, 2	2005-10-18

Company Registrations

SEC

0001351525

Varney Mark A

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.